Table 3.
Multivariate analysis of factors associated with HPV among 1305 WLWH in Uganda
| Variable | Category | Prevalence ratio (PR) (95% CI) | p-value | Multivariate PR (95% CI) | p-value |
|---|---|---|---|---|---|
| Age | Continuous | 0.97 (0.95–0.99) | 0.003 | 0.97 (0.96–0.99) | 0.000 |
| ART Duration | > 10 Years | ||||
| < 4.9 Years | 0.96 (0.61–1.53) | 0.871 | – | – | |
| 5–9.9 years | 0.75 (0.50–1.12) | 0.166 | – | – | |
| ART Status | DTG – Based | ||||
| Non-DTG – Based | 1.24 (0.61–2.52) | 0.550 | – | – | |
| CD4 Category | > 201 | ||||
| < 200 | 0.88 (0.57–1.35) | 0.558 | – | – | |
| Viral Load | Suppressed | ||||
| Non-Suppressed | 1.40 (0.80–2.44) | 0.235 | – | – | |
| BMI Category | 18.6–24.9 | ||||
| 25-29.9 | 0.81 (0.58–1.11) | 0.191 | – | – | |
| 30 above | 0.93 (0.63–1.39) | 0.730 | – | – | |
| < 18.5 | 1.02 (0.55–1.89) | 0.949 | – | – | |
| WHO Stage | Stage I & II | ||||
| Stage III & IV | 1.73 (1.01–2.96) | 0.044 | 1.58 (0.95–2.61) | 0.077 |